Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 114 | 0 | 4 | 16 | 0 |
| Cost of Goods | 48 | N/A | N/A | N/A | N/A |
| Gross Profit | 66 | N/A | 4 | 16 | N/A |
| Operating Expenses | 4,198 | 5,914 | 14,275 | 15,819 | 45,264 |
| Operating Income | -4,085 | -5,914 | -14,272 | -15,803 | -45,264 |
| Interest Expense | 1,183 | 1,217 | 3,447 | 271 | 388 |
| Other Income | -3,358 | -803 | -2,101 | -876 | -4,286 |
| Pre-tax Income | -8,626 | -7,934 | -19,819 | -16,950 | -49,938 |
| Net Income Continuous | -8,626 | -7,934 | -19,819 | -16,950 | -49,938 |
| Minority Interests | -450 | -618 | -298 | -2,707 | -1,685 |
| Net Income | $-8,175 | $-7,316 | $-19,521 | $-14,243 | $-48,253 |
| EPS Basic Total Ops | -19,030.00 | -20.00 | -90.00 | -90.00 | -490.00 |
| EPS Basic Continuous Ops | -20,075.57 | -24.74 | -91.46 | -110.60 | -506.95 |
| EPS Diluted Total Ops | -19,030.00 | -20.00 | -90.00 | -90.00 | -490.00 |
| EPS Diluted Continuous Ops | -20,075.57 | -24.74 | -91.46 | -110.60 | -506.95 |
| EPS Diluted Before Non-Recurring Items | -20.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,436 | $-4,111 | $-10,371 | $-5,653 | $-9,585 |